HCA Healthcare, Inc.
Price Action
Technical Summary
CONSOLIDATINGHCA Healthcare, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 31), showing significant lag compared to the market leaders. Earnings growth of 11% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $386.55 | +7.90% | ABOVE |
| 50 SMA | $402.56 | +3.60% | ABOVE |
| 100 SMA | $455.91 | -8.52% | BELOW |
| 150 SMA | $464.71 | -10.25% | BELOW |
| 200 SMA | $459.85 | -9.30% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HCA in an uptrend right now?
HCA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is HCA overbought or oversold?
HCA's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is HCA outperforming the market?
HCA has a Relative Strength (RS) Rating of 31 out of 99. HCA is currently lagging the broader market.
Where is HCA in its 52-week range?
HCA is trading at $417.07, which is 75% of its 52-week high ($556.52) and 38% above its 52-week low ($330.00).
How volatile is HCA?
HCA has a Beta of 0.17 and 52-week volatility of 28%. It's less volatile than the S&P 500 - generally more stable.